CELLPOINT — Cell Point (India) Income Statement
0.000.00%
- IN₹327.00m
- IN₹704.65m
- IN₹3.21bn
Annual income statement for Cell Point (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,776 | 2,230 | 2,692 | 2,957 | 3,212 |
Cost of Revenue | |||||
Gross Profit | 458 | 362 | 477 | 571 | 514 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,698 | 2,166 | 2,596 | 2,786 | 3,144 |
Operating Profit | 77.9 | 63.7 | 95.7 | 171 | 67.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.9 | 12.7 | 24.3 | 98.7 | 27.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16 | 6.91 | 16.5 | 67.3 | 16.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 16 | 6.91 | 16.5 | 67.3 | 16.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16 | 6.91 | 16.5 | 67.3 | 16.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.856 | 0.37 | 0.881 | 4.93 | 0.965 |
Dividends per Share |